CELLIXEN INC
CAMBRIDGE, MACellixen Inc is a contract R&D provider specializing in cell line engineering and in vitro pharmacology. The company designs tailored strategies and custom engineering vectors for specific cell types, delivering engineered cells that are QC-tested to verify desired modifications. Cellixen reports 350+ cell lines successfully delivered with a success rate over 95% and 10,000+ CRISPR editing events performed.
cell culture and transfection optimizationcell sorting and clonal expansionCRISPR-Cas9 gene editingCRISPR screeningengineering vector design and synthesis (ssDNA, plasmid, transposon, lentivirus, AAV)functional validation (qPCR, ddPCR, FACS, WB, ELISA)genotype verification (Sanger, NGS)HDR template design and productionkaryotypingmycoplasma testingnucleofectionsgRNA screeningvirus infectionvirus packaging